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Bovine viral diarrhea (BVD) is an economically important disease of cattle.
Calves persistently infected (PI) with the bovine viral diarrhea virus (BVDV) are a
powerful agent for spread of the virus. A total of 24,423 southeast origin beef cattle
comingled at three Warren County, Kentucky locations were tested from November 2007
to June 2010 for PI BVDV. A total of 97 head tested positive for PI BVDV, giving an
average overall prevalence of 0.397%.
Calves tested were subdivided into categories for additional calculations of
dependence. A total of 8,910 were categorized by weight range upon testing (300-399
lbs, 400-499 lbs, 500-599 lbs, and 600-699 lbs). Prevalence does show a dependence on
weight, with a higher prevalence found in lower weight classes, especially 300-399 lb
calves (P<0.001). A total of 24,423 were categorized by season at time of testing (Fall,
Winter, Spring, Summer). Prevalence does not show a dependence on season (P>0.05).
Although eradication programs are not likely to be organized in the United States,
several control programs have been developed. These findings can be used as additional
support for PI testing of calves, especially those in lighter weight classes, as part of a
BVD control program.
v

Chapter One
Introduction
Bovine Viral Diarrhea (BVD) is a major disease that negatively affects beef and
dairy cattle worldwide. The Bovine Viral Diarrhea Virus (BVDV) is a single-stranded
RNA virus that is not usually fatal, but has a negative impact because it suppresses the
immune system of infected cattle and makes them more susceptible to other diseases
(Bolin, Grooms, 2004). Cattle affected by BVDV can be of any age; older cattle may
have reproductive failure, abortions, and decreased performance and production, and
calves may experience lower weaning weights and rates of gain (van Campen, 2010).
BVDV can affect every aspect of a beef operation, from seed-stock, cow-calf, stocker
operations, to feedlots (Ridpath, 2009). Because of these conditions, producers
experience an overall economic loss when cattle are affected by BVDV.
A major source of BVDV is cattle that are persistently infected (PI). PI calves
shed extremely high numbers of virus particles for life, making them a powerful agent for
its spread (Fulton, 2005). A calf becomes persistently infected when it is exposed as a
fetus to the BVD virus between days 42 and 125 of gestation (Fulton et al., 2009). For a
PI calf to become exposed, the dam must be either persistently infected herself, or she
must have been exposed to the virus at this period of gestation (Fulton et al., 2009).
BVD is not a new disease in cattle, as it was first identified in the 1940’s
(Ridpath, 2010). However, because of the development and availability of new tools and
diagnostic tests to identify PI animals, there has been an increase of interest in this area
and in the possibility of control or eradication of BVD. Diagnostic tests for detection of
PI animals include antigen-based testing methods such as antigen-capture ELISA
1

(Ridpath, 2009). Testing and removing PI animals helps break the BVD cycle and
decreases the spread of the virus. Controlling the disease requires identifying and
eliminating PI cattle from the herd, maintaining good records, developing a plan to keep
PI cattle from entering the herd, and keeping a PI calf from being created in the herd by
developing and following a sound vaccination program (Brock et al., 1998).
This study was developed to gain a better understanding of the prevalence of PI
beef cattle of southeast US origin comingled in Warren County, KY. It was also
developed to determine whether there is a significant relationship or dependence between
prevalence and weight classes, or prevalence and season.
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Chapter Two
Review of Literature
BACKGROUND- HISTORY AND CLASSIFICATION OF BVDV
The first recorded observation of bovine viral diarrhea (BVD) dates to 1946, in a
New York dairy (Olafson et al., 1946). The new disease was found to cause leukopenia,
pyrexia, depression, diarrhea, anorexia, gastrointestinal erosions, and hemorrhages in
cattle (Ridpath, 2010). In 1957, the causative viral agent was isolated and termed the
bovine viral diarrhea virus (BVDV) (Lee et al., 1957).
Along with classical swine fever virus (CSFV) found in hogs and border disease
virus (BDV) found in sheep, BVDV is currently classified as a member of the genus
Pestivirus within the family Flaviviridae (Fan, Wang, 2009). BVDV is a single-stranded,
positive-sense RNA virus, and is classified based on genotype and biotype (Fray et al.,
2000).
The two genotypes, BVDV1 and BVDV2, are based on phylogenetic analysis of
differences in the viral genome, and also on antigenic differences; antigenic differences
are shown by differences in cross-neutralization and monoclonal antibody binding
patterns (Bachofen et al., 2010; Fulton et al., 2006; Ridpath, 2010). The BVDV1 and
BVDV2 genotypes can be further divided into subgenotypes: 12 subgenotype groupings
within the BVDV1 species (BVDV1a, BVDV1b, etc) and two subgenotype groupings
within the BVDV2 species (BVDV2a and BVDV2b) (Ridpath, 2010). Genotypes of the
BVDV are about 60% similar to each other at their base sequence, and subgenotypes are
about 80% to 85% similar to each other (Bolin, Grooms, 2004). Subgenotypes BVDV1a,
BVDV1b, BVDV2a, and BVDV2b are the most common that are found in North
3

America (Fulton et al., 2006). Predominance of these different BVDV subgenotypes
varies according to different geographic locations (Ridpath, 2010). This is accounted for
most likely by routes of movement of cattle, vaccine usage, and geographic isolation of
cattle populations (Bolin, Grooms, 2004).
Independent of genotype, BVDV strains are also classified by biotype based on
their effect on cultured cells. The non-cytopathic (NCP) biotype replicates in cultured
cells without inducing cell death, while the cytopathic (CP) biotype induces cytoplasmic
vacuolation and cell death of cultured cells within a few days of infection (Fray et al.,
2000; Ridpath, 2010). In the field, the NCP biotype is most common, while the CP
viruses are more rare (Fray et al., 2000; Ridpath, 2010). CP viruses are usually coisolated
with a NCP virus from tissues of cattle with signs of mucosal disease (Bolin et al., 2009;
Ridpath, 2010). CP viruses are the result of either homologous or heterologous
recombination of the parent NCP viral RNA; reversion of the CP virus back to the NCP
biotype may also occur (Bolin, Grooms, 2004; Bachofen et al., 2010).
Like other RNA viruses, the BVDV is able to mutate rapidly (Bolin, Grooms,
2004; Bolin et al., 2009).

EFFECTS OF BVDV
The BVDV can be spread in a variety of ways, including transmission from
acutely infected cattle, by inanimate objects that may carry the virus, bovine sera, rectal
examination, fluids used for embryo transfer, infected semen, and contaminated vaccines
(Fray et al., 2000).
4

Following infection with BVDV, depending on the agent, host, and environment,
a wide range of outcomes can occur that vary in severity. Factors include “whether the
host is immunotolerant or immunocompetent to BVDV, immune status (passive from
colostral antibodies or active from exposure or vaccination), pregnancy status in females,
gestational age of the fetus at the time of infection, level of environmental stress at the
time of infection, and concurrent infection with other pathogens” (Bolin, Grooms, 2004).
The majority of BVDV isolates are of low virulence and induce subclinical to
very mild disease; subclinical infections can result in mild fever, leukopenia, and in the
majority of unvaccinated cattle, development of serum-neutralizing antibodies (Bolin,
Grooms, 2004). It is estimated that 70% to 90% of BVDV infections are subclinical
(Ames, 1986).
However, BVDV infections may also lead to clinical disease; in cattle, the BVD
virus causes diseases that are termed BVD, mucosal disease, chronic BVD, virulent acute
BVD, and hemorrhagic syndrome (Bolin et al., 2009). BVD most commonly results in
lethargy, anorexia, fever, diarrhea, and decreased milk production in lactating cows
(Bolin, Grooms, 2004). Severe BVD causes high morbidity; this peracute infection is
characterized by fever, pneumonia, and sudden death in all age groups of cattle (Carman
et al., 1998). Acute BVD infections can lead to hemorrhagic syndrome, which can cause
severe thrombocytopenia, bloody diarrhea, epistaxis, hemorrhages on mucosal surfaces,
hyphema, bleeding from injection sites, pyrexia, leukopenia, and death (Corapi et al.,
1990). Except in the cases of some hypervirulent type 2 BVDV strains that cause the
lethal severe acute BVD, most of the BVDV biotypes cause acute infection, and the hosts
can effectively clear the virus by their own immunity (Fan, Wang, 2009).
5

Pestiviruses encode two unique proteins that have an affinity for cells involved in
the immune system: a nonstructural protein (Npro) that suppresses the host’s immune
system by preventing production of type I interferon, and an envelope glycoprotein (Erns)
that prevents the induction of beta interferon by binding to and degrading double-stranded
RNA (Ridpath, 2010). As a member of the Pestivirus genus, BVDV can cause infection
resulting in immunosuppression of the host, increasing its susceptibility to other
pathogens and enhancing the pathogenicity of any coinfecting pathogen (Bolin, Grooms,
2004). BVDV infections have been associated with Mannheimia haemolytica, bovine
herpesvirus-1, bovine respiratory syncytial virus, salmonellosis, Escherichia coli, bovine
popular stomatitis, rotavirus, and coronavirus infections (Bolin, Grooms, 2004). BVDV
has been reported as the most common virus isolated from outbreaks of bovine
respiratory disease (BRD) in the United States (Bolin, Grooms, 2004). It usually does not
cause disease alone, but can work with M haemolytica (Potgieter et al., 1984), bovine
herpesvirus (Potgieter et al., 1984), or the bovine respiratory syncytial virus (Broderson,
Kelling, 1998) to cause BRD, especially in a stressful environment.
BVDV also has a major effect on reproduction in cattle. In infected bulls, semen
quality may decrease, and infected cows may have decreased conception rates, increased
early embryonic deaths, abortions, and still-births, and calves may have congenital
defects (Bolin, Grooms, 2004; Fray et al., 2000; Bolin et al., 2009). Conception rates may
fall by up to 44% (Fray et al., 2000). If the dam becomes exposed to the BVDV during
mid-gestation, a higher rate of congenital abnormalities occur, such as alopecia,
pulmonary hypoplasia, retarded growth, thymic aplasia, ataxia, cerebellar hypoplasia,
CNS defects, and ocular lesions (Fray et al., 2000). If the dam becomes exposed to the
6

BVDV later in gestation, congenital abnormalities still occur but are less common, and
there is still a risk of abortion; however, most calves infected late in gestation are born
clinically normal and have high levels of pre-colostral antibodies (Fray et al., 2000).
In regards to spread of the disease, the greatest effect of BVDV occurs when the
dam is exposed to the virus early in gestation, between days 42 and 125; through
transplacental infection, the fetus can become immunotolerant to and is persistently
infected (PI) with the BVDV (Bolin, Grooms, 2004; Fulton et al., 2009).
Type 1 BVDV more often results in PI, congenital defects, and weak calves, and
Type 2 BVDV more often results in aborted fetuses (Evermann, Ridpath, 2002).
Costs associated with BVD can vary according to the type of operation. Ridpath
(2002) states that BVD can result in costs of $35.00 to $65.00 per calving on a US dairy.
Costs on a US beef cow-calf operation can range from $15.33 to $20.16 per cow (Larson
et al., 2002), and are $41.17 per head on a US beef feedlot (Hessman, 2006).

PI CALVES
Only the NCP biotype can cause persistent infection (PI) of the fetus (Bachofen et
al., 2010; Bolin et al., 2009). As a result of fetal infection before the onset of
immunologic competence, PI calves are immunotolerant to the infecting viral strain,
differing from other persistent viral infections in humans and animals (Bachofen et al.,
2010; Bolin et al., 2009; Peterhans et al., 2006). Immunotolerance in the PI calf is
specific to only the particular infecting BVDV strain (Bolin, Grooms, 2004). The PI calf
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remains infected for life and sheds large quantities of the virus (Bachofen et al., 2010). A
PI calf sheds one million to 10 million virus particles every day of its life, in comparsion
to a BVD animal, which sheds 1,000 to 10,000 virus particles a day for a period of only
six to 10 days (IDEXX Laboratories Inc., 2008). Because of the efficiency by which PI
animals can spread BVDV, PI animals should be accounted for and included in any
control or eradication program.
Calves born PI may either be stunted and weak, or normal in size and in
appearance; although some PI calves appear clinically normal, they frequently are poor
doers and have a short life span and leave the herd prematurely (Fray et al., 2000; Bolin
et al., 2009). PI animals often have chronic intestinal or pulmonary symptoms, and may
also have dermatological, neurological, or haematological disorders (Bachofen et al.,
2010). Persistent infection not only affects the fetus, but it can also affect the immune
response of the dam by leading to down-regulation of important signaling pathways in
her blood (Drovers, 2009).
If a PI calf is exposed to a CP BVDV biotype, mucosal disease (MD) may occur
(Bolin, Grooms, 2004). Both NCP and CP BVDV biotypes will be isolated in MD, which
helps in diagnosis of the disease (Bachofen et al., 2010). Not every combination of NCP
and CP virus will result in MD; the CP biotype must be homologous to the persisting
NCP biotype (Bolin, Grooms, 2004). MD can occur in both BVDV Type 1 and Type 2
genotypes (Bolin, Grooms, 2004). Modified-live BVDV vaccines and super-infection
with the CP BVDV can lead to MD (Bolin, Grooms, 2004). The disease is usually lethal,
and causes mucosal lesions, destruction of the lymphoid tissue in the gastrointestinal
tract, and untreatable diarrhea (Bachofen et al., 2010).
8

PI calves have an effect on every sector of the beef cattle industry. After exposure
of the susceptible nonvaccinated penmates to a PI calf in a feedlot situation, 70% to
100% become infected with BVDV (Fulton et al., 2005; Fulton et al., 2006). According
to Loneragan and colleagues (2005), 15.9% of initial cases of BRD are attributable to
exposure to PI calves. According to van Campen (2010), feedlots are the endpoint for the
BVD virus in terms of transmission, but the economic effect is easily seen on feeder
calves, which accounts for strong interest in control of BVDV in this segment of the
industry.
In cow-calf operations, synchronous, seasonal breeding is common, and,
depending on the time of exposure, contact with a single PI calf through shared pasture
can have significant detrimental effects on the pregnant cows: there may be an increase in
infertility, abortions, stillbirths, and birth of calves that are weak or stunted (van Campen,
2010). If the dam is exposed to the BVDV and a PI calf is created, but it is either not born
or dies before it is able to infect the breeding herd, there is no sustained effect of BVDV
infection on the herd (van Campen, 2010). However, if the PI calf survives into the
breeding season, the herd may enter an endemic state of infection (van Campen, 2010).
After PI exposure and BVDV infection of the breeding herd, up to 50% of the calf crop
may be lost (van Campen, 2010). Of those exposed calves that survive, many will
experience diarrhea and pneumonia after maternal antibodies wane, and will also have
lower weaning weights and lower rates of gain (van Campen, 2010).
In addition to shared pastures, high risk practices in the beef industry also include
heifer development feedlots and the purchase of untested cattle and pregnant heifers (van
Campen, 2010). Purchased cattle also often pass through multiple sales facilities, or may
9

be purchased from multiple sources and then comingled at a high animal density (van
Campen, 2010).

DETECTION OF PI CALVES/ DIAGNOSTIC TOOLS
Since persistently infected animals are a continuous source of the BVDV, the
identification and removal of PI animals is an important part of any prevention or control
program (Brock et al., 1998). After the wane of maternal antibodies, PI calves usually
have detectable amounts of the NCP virus in their serum, with concentrations of 104- 106
CCID50/ mL of serum (Brock et al., 1998). A variety of diagnostic tools are available
that may target the viral antigens (ex: immunoperoxidase microtiter assay, antigencapture [Ag]ELISA, immunochemistry [IHC], fluorescent antibody), genomic material
(ex: traditional and real-time reverse transcription PCR, in situ hybridization), or BVDV
specific antibodies (ex: virus neutralization, antibody ELISA) (Bolin, Grooms, 2004;
Brock et al., 1998).
In antigen detection assays, either monoclonal or polyclonal antibodies are used to
detect BVDV antigens (Bolin, Grooms, 2004). Monoclonal antibodies are specific for a
single epitope, and binding of the antibody may not occur if there is any epitope variation
between viruses (Bolin, Grooms, 2004). However, polyclonal antibodies react with
multiple epitopes, and these are often conserved among viruses (Bolin, Grooms, 2004).
Therefore, “most antigen detection assays use polyclonal antibodies or a pool of
monoclonal antibodies to provide the broadest reactivity and capability of detecting a
diverse population of BVDV isolates” (Bolin, Grooms, 2004).
10

Antigen detection assays such as IHC and AgELISA are very accurate and cost
effective at detecting both BVDV-infected calves and PI calves (Cornish et al., 2005).
Although tested individually, large numbers of animals can be tested without difficulty
because samples can be easily collected when calves are processed or handled, either by
obtaining ear notches or blood samples (Cornish et al., 2005). According to Cornish and
colleagues (2005), the IHC test provides results in 5 days, while the more time-efficient
and less labor-involved AgELISA test can provide results in as soon as one day. Since
both acute and persistent infection result in a positive diagnosis, a positive animal should
be tested again 30 days after the initial test to make a final diagnosis (Cornish et al.,
2005). Testing is also cost-efficient, as the AgELISA test offered through IDEXX
(HerdChek BVD Antigen Test Kit) costs less than $5 per head (IDEXX, 2008). The
IDEXX HerdChek BVD Antigen Test Kit is a USDA-licensed test based on the Erns
(gp48) antigen, and it detects both type 1 and type 2 BVDV, with 100% sensitivity and
100% specificity on skin samples (IDEXX, 2008).
Edmonson and colleagues (2007) state that isolation of the viral antigen from
serum and then identification of the viral isolate by immunofluorescence or
immunoperoxidase monolayer assay is one of the most reliable diagnostic techniques.
Polymerase chain reaction (PCR) detects and amplifies the viral genomic
sequence (Bolin, Grooms, 2004). Pooling of samples is common when using PCR as a
diagnostic tool; when determining the size of the pool, the pooling protocol should use
the fewest number of tests required to identify all animals PI with BVDV in a herd
(Edmonson et al., 2007). According to Edmonson and colleagues (2007), there is an
inverse ratio between prevalence and pool size: the optimum number of samples in an
11

initial pool would be 20 to 30 for a PI prevalence of 0.5% to 1.0%, and as prevalence
increases the least-cost initial pool size decreases.

CONTROL OF DISEASE
Testing is the only way to correctly identify PI calves, as they are not always
identifiable based on sight. Therefore, testing and removal of PI animals should be an
important part of any control program (Brock et al., 1998).
Vaccination is also an important facet of control; an estimated 80% of cattle in the
US are vaccinated with either inactivated or modified live viral vaccines (MLV)
containing BVDV (USDA, 1995; USDA, 2007). Control programs include the use of
inactivated and MLV BVDV vaccines to prevent fetal infections, reproductive losses, and
acute infections (van Campen, 2010). Prior to 2004, vaccines contained cytopathic Type
1a BVDV (either Singer or NADL), but after the recognition that Type 2 BVDV can lead
to severe disease and fetal losses, a cytopathic Type 2 BVDV was also included in many
vaccines (van Campen, 2010). MLV vaccines have been shown to offer superior
protection, but there are still some concerns about their safety and effects on health (van
Campen, 2010).
Vaccine failure is most common and fetal protection is most limited when the
challenge virus is a different genotype than the vaccine virus (Bolin et al., 2009). Several
studies do show vaccination with Type 1 BVDV does induce some clinical cross
protection against Type 2 challenge (Bolin, Grooms, 2004). However, Drovers (2009)
cites a study in which Fulton and colleagues found that the majority of viral isolates from
12

PI cattle were of the BVDV Type 1b subtype, while current USDA approved vaccines
primarily contain BVDV Type 1a and Type 2a, suggesting that complete protection is not
offered. Vaccination of feeder calves is beneficial, but to gain complete protection,
ideally, vaccination should also include the breeding herd for control of reproductive
failure and prevention of fetal infection, and the subsequent birth of PI calves (Bolin,
Grooms, 2004; Fernandez et al., 2009). Regarding fetal protection, complete cross
protection may not be provided from current vaccines; according to Bolin and Grooms
(2004), experimental fetal protection trials have ranged in efficacy from 25% to 100%,
depending on the type of challenge virus and vaccine virus.
Vaccine strategies are varied, and many focus on vaccination at critical periods of
production (Bolin et al., 2009). However, vaccines are often not given consistently or
appropriately (Carruthers, Petrie, 1996). According to Bolin and colleagues (2009), three
assumptions are often made that may lead to failure of a vaccine program; these
assumptions are that the vaccine was handled properly before vaccination, that the herd
was appropriately vaccinated, and that all cattle within the herd have an equal immune
response to the vaccine. Producers that do not take these assumptions into account may
experience apparent vaccine failure (van Campen, 2010).
Any control program that includes proper vaccination and testing should also
include strict biosecurity measures to sustain a BVDV-free population (Fray et al., 2000).
The number of BVD control programs has increased since 2003, when the Academy of
Veterinary Consultants published a position statement (http://www.avcbeef.org/links/BVDLinks.asp) on the control and possible eradication of BVD in the
United States (van Campen, 2010). According to van Campen (2010), as of 2010 there
13

are beef control programs in Alabama, Colorado, Georgia, Mississippi, Montana, Oregon,
and Washington, and a dairy control program in New York. The current control programs
are all voluntary, associated with a university, and work along with other beef and dairy
quality assurance programs (van Campen, 2010). The control programs include
“education about BVDV transmission and diseases, required testing procedures,
documentation of biosecurity practices to prevent re-introduction of BVDV, and verified
use of a vaccination schedule” (van Campen, 2010).
Although mandatory BVD control programs exist in several European countries,
there are not currently any mandatory programs in place in the United States (van
Campen, 2010). Several obstacles exist, including the need for a control program to be
government-regulated, and the belief that there is a lack of clear danger, based on low
herd prevalences (van Campen, 2010).
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Chapter Three
Materials and Methods
As an initial step, in the fall of 2009, a visit was made with Sandy Grant at the
Gold Standard diagnostic lab in Bowling Green, KY, to discuss the Bovine Viral
Diarrhea Virus and the methods used at the lab for testing persistently infected (PI) cattle.
Several additional visits were conducted to gain experience in running the AgELISA
diagnostic test (IDEXX HerdChek BVD Antigen Test Kit) used at this location. Also in
the fall of 2009, a visit was made to Farm A in Warren County, KY, to gain knowledge
on obtaining ear-notch and serum samples. PI test results (positive or negative) from
November 2007 to June 2010 were obtained from the herd veterinarian in Bowling
Green, KY on beef cattle from Farms A and B. Additional test results and weight range
of those tested were obtained from Farm C. Data for this study were obtained first hand
by collecting ear-notch and serum samples, then testing them at Gold Standard diagnostic
laboratory, and also by obtaining previous and current testing records. Records were
obtained from Farms A and B herd veterinarian for positive or negative test results on
cattle from November 2007 to June 2010. Records were obtained from Farm C diagnostic
lab for results from April 2009 to June 2010.
Study animals from each beef operation were of Kentucky, Tennessee, or
Alabama origin, and ranged from 300 to 600 pounds when processed upon arrival. All the
calves were assumed to be naïve to vaccination when initially processed. All calves that
were purchased and processed were tested to determine if they were persistently infected
with the bovine viral diarrhea virus.
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Ear notching was the most common method by which samples for testing were
obtained. Calves were restrained in a chute and, using V-type ear-notchers, a full notch
was taken from the top portion of the ear to reduce the amount of hair. The notch was
placed in a sample vial containing enough phosphate buffered solution (PBS) for the
sample to be submerged. The sample vial was labeled, and the corresponding animal ID’s
and sample vial ID’s were recorded. To reduce spread of disease and to decrease chances
of inaccurate test results, the ear notchers were then rinsed in a clean water vessel to
remove any hair, then disinfected in a vessel containing diluted chlorhexidine (1 ounce
chlorhexidine: 1 gallon water), and then in another clean water vessel to rinse remaining
disinfectant. After all the ear-notch samples were gathered, the sample vials were
immediately boxed in trays along with cold packs and lab submission forms and sent to
the appropriate lab for diagnostic testing. Samples not sent out were refrigerated and then
sent as soon as possible.
Blood collection was a less common method by which samples for testing were
obtained. While the calf was restrained in the chute, a 3 cc blood sample from either the
neck or the tail was collected in a marble top tube. The sample was centrifuged and the
serum was sent to the appropriate diagnostic lab for testing.
Samples from Farms A and B were tested for PI BVDV with an antigen capture
ELISA test at the Elizabethtown, KY, Central States Testing diagnostic lab location.
Samples from Farm C were tested for PI BVDV with an antigen capture ELISA
test at the Bowling Green, KY, Gold Standard diagnostic lab location.
Results from the diagnostic labs were available within as few as 5 hours.
16

Data from Farms A, B, and C were compiled in a Microsoft Excel spreadsheet
and organized by specific location, date, total number tested, and number testing positive
and negative.
Data from Farm C were also grouped by weight range at time of testing.
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Chapter Four
Results
All data obtained from beef cattle testing positive or negative for persistent
infection with BVDV from November 2007 to June 2010 are listed by date and location
in Table 1. A total of 97 out of 24,423 tested positive as PI BVD, giving an overall
prevalence of 0.397%.

Table 1. Beef cattle testing positive for PI BVD by location (Nov 2007 to June 2010).

Location

Total number
tested
FARM A
9271
FARM B
6242
FARM C
8910
TOTAL 24,423

Total number
positive
39
24
34
97

Prevalence (%)
0.421
0.384
0.382
0.397

Data obtained from Farm C cattle testing positive or negative for persistent
infection with BVDV from April 2009 to June 2010 are listed by weight range in Table 2.
Calves were grouped by weight range regardless of season.

Table 2. Farm C- beef cattle testing positive for PI BVD by weight range (April 2009 to June 2010).

Weight range (lbs)
300-399
400-499
500-599
600-699

Total number
tested
1491
3283
3694
442

Total number
positive
15
9
9
1
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Prevalence (%)
1.006
0.274
0.244
0.226

Data obtained from beef cattle at all three farm locations testing positive for PI
BVD from November 2007 to June 2010 are listed by season in Table 3.

Table 3. Beef cattle testing positive for PI BVD by season (Nov 2007 to June 2010).

Season

Total number
tested
7419

Fall
(Sept 22- Dec 21)
Winter
4459
(Dec 22- March 21)
Spring
8189
(March 22- June 21)
Summer
4356
(June 22- Sept 21)

Total number
positive
28

Prevalence (%)

15

0.336

36

0.440

18

0.413

19

0.377

A contingency chi-square was used to determine if prevalence of PI BVDV has
dependence on weight (Table 4). The calculated χ2 value of 18.362 is greater than critical
χ2 values at the 0.05, 0.01, and 0.001 levels: 7.815, 11.345, and 16.266, respectively.
Therefore, the null hypothesis is rejected at the 0.001 level; frequency (prevalence) does
depend on category (weight), and the major contributor to the outcome is in the first
category (300-399 lbs).

Table 4. Contingency Chi-Square; Farm C beef cattle testing positive for PI BVD by weight.

Weight
range (lbs)
300-399

O
E
(O-E)2/ E

400-499

O
E
(O-E)2/ E

500-599

O
E
(O-E)2/ E

600-699

O
E
(O-E)2/ E

Total

Positive

Negative

Total

15
5.69
15.23
9
12.53
0.94
9
14.10
1.84
1
1.69
0.28
34

1476
1485.31
0.06
3274
3270.5
0.004
3685
3679.90
0.007
441
440.31
0.001
8876

1491
3283
3694
442
8910

χ2 = ∑ (O-E)2/ E
calculated χ2 = 18.362; df = 3
critical χ2 (0.05, 3) = 7.815
critical χ2 (0.01, 3) = 11.345
critical χ2 (0.001, 3) = 16.266
In the contingency chi-square, O= observed frequency and E= expected frequency in
each classification. E is calculated by multiplying the respective row total by the
respective column total and dividing by the overall total. The 15.23 component of the χ2
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for the 300-399 lbs positive classification= 34 x 1491/ 8910= 5.69; (15-5.69)2/ 5.69=
15.23. The sum of the (O- E)2/ E values for all the classification combinations= χ2. A
significant χ2 indicates dependence between the variables.
A second contingency chi-square was used to determine if prevalence of PI
BVDV has dependence on season (Table 5). Since the calculated χ2 value of 0.8909 is
less than the critical χ2 value of 7.815, the null hypothesis is accepted at the 0.05 level;
frequency (prevalence) does not depend on category (season).

Table 5. Contingency Chi-Square; Beef cattle testing positive for PI BVD by season.

Season
Fall

O
E
(O-E)2/ E

Winter

O
E
(O-E)2/ E

Spring

O
E
(O-E)2/ E

Summer

O
E
(O-E)2/ E

Total

Positive
28
29.466
0.0729
15
17.710
0.4147
36
32.524
0.3715
18
17.301
0.0282
97

Negative
7391
7389.534
0.0003
4444
4441.290
0.0017
8153
8156.476
0.0015
4338
4338.699
0.001
24326

χ2 = ∑ (O-E)2/ E
calculated χ2 = 0.8909
df = 3
critical χ2 (0.05, 3) = 7.815
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Total
7419
4459
8189
4356
24423

Chapter Five
Discussion
Results from this study may be used as additional support for PI testing as part of
a BVDV control program. Data show an overall prevalence of 0.397% of sale barn
animals as persistently infected with BVDV. Although prevalence does not depend on
season, there is a higher prevalence of PI BVDV in lighter weight calves, especially those
ranging in weight from 300 to 399 pounds (P<0.001). Although there is a seemingly low
prevalence, these PI calves have a significant detrimental impact on other animals they
come in contact with as a result of shedding abnormally high numbers of BVDV
particles. Although the feedlot is an endpoint in terms of virus transmission, BVDV still
has a great economic effect on this segment of the industry. Producers may feel that there
is not an even trade-off between costs and benefits of testing, but data from this study
show a uniform prevalence, and a testing and control program would be very beneficial.
Although the development of a government funded eradication program is not
likely in the United States, the control of BVD is nevertheless important, and several
control programs are currently in place. A major concern of any control program should
include testing for and removal of any calves that are PI, and maintaining accurate
records and documentation of testing. Once an animal has been tested PI negative, there
is no need to retest it for PI. PI animals should be removed from the herd; they may be
either humanely slaughtered, or grouped together in an isolated pen to prevent the spread
of the virus, and then raised to market weight. A vaccination and testing program should
also be developed that is specific for the type of operation, and vaccines should be given
correctly. Producer failure appears to be more often at fault than vaccination failure.
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Based on data from this study, PI testing and removal would be beneficial, and is
especially justified in lighter weight sale barn calves.
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